These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 14558407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
    Barnadas M, Roe E, Brunet S, Garcia P, Bergua P, Pimentel L, Puig L, Francia A, García R, Gelpí C, Sierra J, Coll P, Alomar A.
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):69-74. PubMed ID: 16405612
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR, Bastian BC, Wesselmann U, Karl S, Hamm H, Bröcker EB.
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [Abstract] [Full Text] [Related]

  • 8. Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus--an update.
    Arin MJ, Hunzelmann N.
    Eur J Dermatol; 2005 Dec; 15(4):224-30. PubMed ID: 16048747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A case of follicular lymphoma complicated with lethal pemphigus].
    Imataki O, Tamai Y, Abe Y, Ito I, Yoshikawa S, Kawakami K.
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
    Prodanovic EM, Korman NJ.
    J Dermatolog Treat; 2008 Nov; 19(6):1-3. PubMed ID: 18720187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
    Bech R, Baumgartner-Nielsen J, Peterslund NA, Steiniche T, Deleuran M, d'Amore F.
    Br J Dermatol; 2013 Aug; 169(2):469-72. PubMed ID: 23517368
    [Abstract] [Full Text] [Related]

  • 15. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
    Martínez De Pablo MI, Iranzo P, Mascaró JM, Llambrich A, Baradad M, Herrero C.
    Acta Derm Venereol; 2005 Aug; 85(3):233-5. PubMed ID: 16040408
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
    Plumb R, Doolittle GC.
    Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
    [Abstract] [Full Text] [Related]

  • 18. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Taintor AR, Leiferman KM, Hashimoto T, Ishii N, Zone JJ, Hull CM.
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
    Allen KJ, Wolverton SE.
    J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.